Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abstral pharmacokinetics in head and neck cancer during chemoradiotherapy
NL-OMON26436Recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fentanyl in cancer pain and breakthrough pain, sponsored by Erasmus MC. Primary endpoint: Fentanyl pharmacokinetics. Started Dec 2014; status: recruiting.
02
Drugs
fentanyl
03
Conditions
cancer painbreakthrough pain
Beyond the preview
Go deeper on NL-OMON26436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26436.